Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Jeisys Medical (287410 KS)
Watchlist
50
Analysis
Health Care
•
South Korea
Jeisys Medical Inc. operates medical device manufacturing businesses. The Company produces diagnostic devices, earpieces, rehabilitation devices, and other medical devices. Jeisys Medical conducts businesses in South Korea.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
HLB Therapeutics
•
20 Sep 2024 17:13
Will New KOSDAQ 150 Member HLB Therapeutics Show Webzen-Like Price Moves?
This post covers the KOSDAQ 150 ad-hoc change, where HLB Therapeutics replaces Jeisys Medical, and explores whether HLB Therapeutics will...
Sanghyun Park
Follow
726 Views
Share
bullish
•
HK inno.N
•
17 Sep 2024 18:52
Korea Value-Up Index Drops on the 24th: Hunt for the Winners in the KOSDAQ Global Index
This post finds beneficiaries within the KOSDAQ Global Index as the Korea Value-Up Index details, including the constituents, will be released on...
Sanghyun Park
Follow
600 Views
Share
bullish
•
Seven & I Holdings
•
14 Sep 2024 15:00
(Mostly) Asia-Pac M&A: Seven & I, Hotel Property, Hulic, Joban Kosan, Dyna Mac, Fuji Soft, Descente
This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...
David Blennerhassett
Follow
655 Views
Share
bullish
•
DL Holdings Co
•
12 Sep 2024 17:10
KRX Releases November SSFs and SSOs Reshuffle: Here's the Breakdown
KRX has released the results of the November reshuffle for SSFs (single-stock futures) and SSOs (single-stock options). This post takes a look at...
Sanghyun Park
Follow
592 Views
Share
bullish
•
Seven & I Holdings
•
07 Sep 2024 15:00
(Mostly) Asia-Pac M&A: Seven & I, Virgin Money, PSC Insurance, Rex Minerals, Namoi, CPMC, China TCM
This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...
David Blennerhassett
Follow
615 Views
Share
Previous
1
2
3
4
5
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x